VNRX - VolitionRx Limited

NYSE American - Nasdaq Real Time Price. Currency in USD

VolitionRx Limited

No. 24-05 Shaw Centre
1 Scotts Road
Singapore 228208
646 650 1351

IndustryDiagnostics & Research
Full Time Employees44

Key Executives

NameTitlePayExercisedYear Born
Dr. Martin Charles FaulkesExec. Chairman151.83kN/A1944
Mr. Cameron ReynoldsFounder, Group CEO, Pres & Director310.17kN/A1971
Dr. Jacob Vincent Micallef Ph.D., MBAChief Scientific Officer151.55kN/A1956
Dr. Jason Bradley TerrellChief Medical Officer182.34kN/A1980
Mr. Rodney Gerard Rootsaert LLBCorp. Sec.126.23kN/A1971
Amounts are as of December 31, 2016 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


VolitionRX Limited, a life sciences company, engages in the development of blood tests to help diagnose a range of cancers and other diseases worldwide. The company develops blood-based Nu.Q immunoassays to detect specific biomarkers. VolitionRX Limited is based in Singapore.

Corporate Governance

VolitionRx Limited’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.